STRO
Price:
$2.84
Market Cap:
$234.18M
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-drug conjugate (ADC) directed against the cancer target CD74 for patients with multiple myeloma and non-Hodgkin lymphoma that is in Phase 1 clinical trials; and STRO-002, an ADC directed against folate receptor-alpha for patients with ovarian and endometrial cancers, which is in Phase 1 clinical trials. It has collaboration and license agreements with M...[Read more]
Industry
Biotechnology
IPO Date
2018-09-27
Stock Exchange
NASDAQ
Ticker
STRO
According to Sutro Biopharma, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 3.09. This represents a change of -20.03% compared to the average of 3.86 of the last 4 quarters.
The mean historical Current Ratio of Sutro Biopharma, Inc. over the last ten years is 4.52. The current 3.09 Current Ratio has changed 6.73% with respect to the historical average. Over the past ten years (40 quarters), STRO's Current Ratio was at its highest in in the December 2020 quarter at 12.78. The Current Ratio was at its lowest in in the March 2017 quarter at 0.
Average
4.52
Median
4.20
Minimum
0.80
Maximum
12.78
Discovering the peaks and valleys of Sutro Biopharma, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 618.71%
Maximum Annual Current Ratio = 12.78
Minimum Annual Increase = -59.03%
Minimum Annual Current Ratio = 0.80
Year | Current Ratio | Change |
---|---|---|
2023 | 4.50 | 102.65% |
2022 | 2.22 | -57.62% |
2021 | 5.24 | -59.03% |
2020 | 12.78 | 227.64% |
2019 | 3.90 | -32.34% |
2018 | 5.76 | 618.71% |
2017 | 0.80 | -19.00% |
The current Current Ratio of Sutro Biopharma, Inc. (STRO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
3.98
5-year avg
5.73
10-year avg
4.52
Sutro Biopharma, Inc.’s Current Ratio is less than Vaxcyte, Inc. (17.88), less than Larimar Therapeutics, Inc. (13.10), less than Syndax Pharmaceuticals, Inc. (6.99), less than Merus N.V. (8.32), less than IDEAYA Biosciences, Inc. (22.93), less than AnaptysBio, Inc. (10.23), greater than MeiraGTx Holdings plc (2.34), less than Keros Therapeutics, Inc. (19.03), less than Homology Medicines, Inc. (4.19), less than NewAmsterdam Pharma Company N.V. (10.61), less than Centessa Pharmaceuticals plc (21.52), greater than Opthea Limited (2.94), less than HilleVax, Inc. (14.25), less than Eliem Therapeutics, Inc. (0), less than Genenta Science S.p.A. (60.41), less than Pardes Biosciences, Inc. (12.25), less than Aerovate Therapeutics, Inc. (9.81), less than Mineralys Therapeutics, Inc. (8.78), less than Replimune Group, Inc. (8.55), less than null (10.11),
Company | Current Ratio | Market cap |
---|---|---|
17.88 | $11.60B | |
13.10 | $387.94M | |
6.99 | $1.44B | |
8.32 | $3.11B | |
22.93 | $2.45B | |
10.23 | $732.72M | |
2.34 | $490.80M | |
19.03 | $2.75B | |
4.19 | $3.02M | |
10.61 | $1.55B | |
21.52 | $2.26B | |
2.94 | $555.53M | |
14.25 | $95.63M | |
0 | $342.68M | |
60.41 | $96.02M | |
12.25 | $135.19M | |
9.81 | $73.63M | |
8.78 | $624.60M | |
8.55 | $992.23M | |
10.11 | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sutro Biopharma, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Sutro Biopharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Sutro Biopharma, Inc.'s Current Ratio?
How is the Current Ratio calculated for Sutro Biopharma, Inc. (STRO)?
What is the highest Current Ratio for Sutro Biopharma, Inc. (STRO)?
What is the 3-year average Current Ratio for Sutro Biopharma, Inc. (STRO)?
What is the 5-year average Current Ratio for Sutro Biopharma, Inc. (STRO)?
How does the current Current Ratio for Sutro Biopharma, Inc. (STRO) compare to its historical average?